Genes in panel
Prev Next

Clefting disorders

Region: ISCA-46303-Loss

SOX9 upstream enhancer loss

Green List (high evidence)

Chromosome: 17
GRCh38 Position: 69896855-71796293
Haploinsufficiency Score: Sufficient evidence suggesting dosage sensitivity is associated with clinical phenotype
Triplosensitivity Score:
Required percent of overlap: 80%
Variant types: CNV Loss

1 review

Sarah Milton (Victorian Clinical Genetics Services)

Green List (high evidence)

Deletion of the upstream enhancer of SOX9 have been associated with Pierre Robin syndrome, campomelic dysplasia, acampomelic dysplasia as well as 46,XY sex reversal.

This region has been curated by Clingen for the Pierre Robin syndrome phenotype and has been called HI3. Coordinates were based on the largest region found in affected individuals.

There are a number of enhancer elements within this region of which there are proposed to be four clusters: a proximal cluster between 50-375 kb, a sex-determining interval RevSex region between 517-595 kb, a distal cluster between 601 and 932 kb, and a PRS cluster between 1.03–1.26 Mb. Defining genotype phenotype has not been conclusively established within the literature in this region however there are some noted correlations.

Incomplete penetrance has been noted for the 46,XY sex reversal with approx 75% of individuals with deletions in this region demonstrating a DSD phenotype ranging from ambiguous genitalia to typical female external genitalia. Note that loss of SOX9 function does not cause sex reversal in individuals with a 46,XX karyotype. See additional entry for gain of this region.

Sources: ClinGen
Created: 6 Feb 2026, 2:14 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Publications

Details

ISCA ID
ISCA-46303-Loss
ISCA Region Name
SOX9 upstream enhancer loss
Chromosome
17
GRCh38 Coordinates
69896855-71796293
Haploinsufficiency Score
Sufficient evidence suggesting dosage sensitivity is associated with clinical phenotype
Triplosensitivity Score
Required percent of overlap
80%
Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • ClinGen
  • ClinGen
Phenotypes
  • Pierre Robin syndrome MIM#261800
Tags
regulatory region
Clinvar variants
Variants in
Penetrance
None
Variant types
CNV Loss
Publications

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
28 Apr 2026, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Region: isca-46303-loss has been classified as Green List (High Evidence).

27 Apr 2026, Gel status: 3

Set Phenotypes, Added Tag

Sarah Milton (Victorian Clinical Genetics Services)

Phenotypes for Region: ISCA-46303-Loss were changed from to Pierre Robin syndrome MIM#261800 Tag regulatory region was added to Region: ISCA-46303-Loss.

27 Apr 2026, Gel status: 3

Entity classified by Genomics England curator

Sarah Milton (Victorian Clinical Genetics Services)

Region: isca-46303-loss has been classified as Green List (High Evidence).

6 Feb 2026, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set publications

Sarah Milton (Victorian Clinical Genetics Services)

Region: ISCA-46303-Loss was added Region: ISCA-46303-Loss was added to Clefting disorders. Sources: ClinGen Mode of inheritance for Region: ISCA-46303-Loss was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for Region: ISCA-46303-Loss were set to PMID: 24934569, 26663529, 19234473, 26152199, 30552336